PharmaVOICE - 
January 2011
Purchase Issue

In Every Issue
Last Word
Pharma Forecast Simon King, a pharmaceutical company analyst at ­Datamonitor, [...]
By
Talent Pool
Pharmaceutical POOL Dr. Milind DESHPANDE Achillion Pharmaceuticals Promotes R&D President [...]
By
Social Media
CMP.LY to Address FDA/FTC Requirements Proponents of using the Internet [...]
By
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: [...]
By
What’s New
Trends: Changing market forces and the trend toward more flexible [...]
By
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: [...]
By
UpFront
Awards… Abbott Diversity Leader John F. Crowley Honored Rx club [...]
By
Reader Feedback
Transforming R&D It was noted in your ­November/December Year in [...]
By
Letter from the Editor
Happy New Decade! Happy New Year to all from ­everybody [...]
By

Taren Grom, Editor

On The Cover

Millennials: Problems or Prodigies?
Our experts say, however, this is a generation worth catering to, because if they are happy, they will most certainly succeed. Getting all four generations to work together effectively is challenging because the generations have difficulty relating to one another as they interact in the workplace. As a result, team leaders must first understand each [...]
By

Robin Robinson

Features

Using Social Media to Listen Before You Leap
e-Patients: Much More Than Targets Technology has given rise to a new kind of patient—one who is empowered, educated, and hungry for information that digital media can provide. These e-Patients have captured the imagination of healthcare marketers, who are poised to spend .12 billion in 2011 (per eMarketer) to reach them. Pharmaceutical companies use a dizzying [...]
By

Chris Kelly, M.ED., Director, Health Education and Jeff Greene, Director, Digital Strategy, HealthEd

Quick Response Codes (QR) Codes – The Next Frontier for Pharma
Those little ink blot-like codes are cropping up everywhere — in consumer newspapers and magazines, out-of-home advertising, brochures, in stores, and elsewhere. When you snap a picture of them with your mobile device they take your handheld to brave new worlds of content. Being QR code savvy might reward you with a special discount coupon [...]
By
Engaging the Empowered E-Patient
Engaging the Empowered E-Patient The growing consumer use and exchange of online health information is changing the ­balance of power in the patient-physician relationship by enabling the consumer to take a more active and informed role in making decisions about their healthcare. n the 2010 edition of its Cybercitizen Health U.S. study, Manhattan Research identified [...]
By

Carolyn Gretton

Emerging Market: Ola Brazil
With every passing year, the pharmaceutical industry becomes more global in its ­ outlook and reach. In recognition of our shrinking world, PharmaVOICE is taking you on a journey across the globe. Our first stop is Latin America’s largest market, Brazil. Brazil is familiar territory to the pharmaceutical industry, which has been operating in the [...]
By

Kim Ribbink

Biotech: Raising Capital in a Tight Market
The global financial crisis has made it challenging for the biotechnology industry to raise capital to fund innovation. Experts say venture capital money is still available, but often the VC community is looking for lower-risk, short-term projects. As a result, biotech companies are increasingly looking to alternative sources of capital. Experts say this is a [...]
By

Denise Myshko

SFE With a New Business Model
There’s been much discussion over the past few years about the industry moving to a more consumer-centric sales model, and the time has come for a little less conversation and a little more action. The myriad challenges facing the industry and the increased adoption of technology by physicians have created the proverbial burning platform. The [...]
By

Robin Robinson

Achieving Global Launch Excellence
The details of what comprise a global launch vary depending upon who is doing the defining, but experts can agree that the launch environment is becoming more challenging. And with the value of the global pharmaceutical market expected to grow 5% to 7% in 2011, according to IMS Health, the incentive to reach multiple markets [...]
By

Taren Grom, Editor

The Genome: The Next 10 Years
In just one generation medicine will take a huge leap forward. That is, if researchers are right about how data from the human genome can be used to address disease. There has been a great deal of optimism about how sequencing the human genome might create new diagnostics and new medicines. Ten years ago, when [...]
By

Denise Myshko

FEEDBACK